6 October 2020 – Inreda is starting a project with Dutch health insurance company Menzis: the artificial pancreas (the Inreda AP) will be used by 100 adults with diabetes type 1. The project starts in October and concerns patients who experience substantial problems with controlling their regulation. The artificial pancreas itself regulates continuously the blood
